{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:02:27Z","timestamp":1766466147202,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1016\/s0959-437x(05)80346-6","type":"journal-article","created":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T07:14:44Z","timestamp":1123226084000},"page":"86-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Poxvirus vectors: cytoplasmic expression of transferred genes"],"prefix":"10.1016","volume":"3","author":[{"given":"Bernard","family":"Moss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-437X(05)80346-6_bib1","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.2047875","article-title":"Vaccinia Virus: a Tool for Research and Vaccine Development","volume":"252","author":"Moss","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0959-437X(05)80346-6_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0958-1669(91)90040-C","article-title":"Vaccinia Virus Vectors for Gene Expression","volume":"2","author":"Smith","year":"1991","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib3_1","series-title":"Current Protocols in Molecular Biology","first-page":"16.16.1","article-title":"Preparation of Cell Cultures and Vaccinia Virus Stocks","author":"Earl","year":"1991"},{"key":"10.1016\/S0959-437X(05)80346-6_bib4","series-title":"Current Protocols in Molecular Biology","first-page":"16.17.1","article-title":"Generation of Recombinant Vaccinia Viruses","author":"Earl","year":"1991"},{"key":"10.1016\/S0959-437X(05)80346-6_bib5","series-title":"Current Protocols in Molecular Biology","first-page":"6.18.1","article-title":"Characterization of Recombinant Vaccinia Viruses and their Products","author":"Earl","year":"1991"},{"key":"10.1016\/S0959-437X(05)80346-6_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/0-89603-178-0:129","article-title":"Manipulation of Vaccinia Virus Vectors","volume":"7","author":"Mackett","year":"1991","journal-title":"Gene Transfer and Expression Protocols"},{"key":"10.1016\/S0959-437X(05)80346-6_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/0-89603-191-8:235","article-title":"Isolation and Handling of Recombinant Vaccinia Viruses","volume":"8","author":"Talavera","year":"1991","journal-title":"Practical Mol Virol"},{"first-page":"1","year":"1992","series-title":"Recombinant Poxviruses","key":"10.1016\/S0959-437X(05)80346-6_bib8_1"},{"key":"10.1016\/S0959-437X(05)80346-6_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-1119(91)90331-5","article-title":"The Hygromycin-Resistance-Encoding Gene as a Selection Marker for Vaccinia Virus Recombinants","volume":"107","author":"Zhou","year":"1991","journal-title":"Gene"},{"key":"10.1016\/S0959-437X(05)80346-6_bib10_1","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1128\/jvi.65.11.5910-5920.1991","article-title":"Extracellular Vaccinia Virus Formation and Cell-to-Cell Virus Transmission are Prevented by Deletion of the Gene Encoding the 37,000 Dalton Outer Envelope Protein","volume":"65","author":"Biasco","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib11","first-page":"564","article-title":"A Rapid Method for Screening Vaccinia Virus Recombinants","volume":"10","author":"Lai","year":"1991","journal-title":"Biotechniques"},{"key":"10.1016\/S0959-437X(05)80346-6_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0166-0934(91)90129-N","article-title":"Direct Identification of Recombinant Vaccinia Virus Plaques by PCR","volume":"35","author":"Pasamontes","year":"1991","journal-title":"J Virol Methods"},{"key":"10.1016\/S0959-437X(05)80346-6_bib13_1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0042-6822(92)91246-Q","article-title":"Introduction of Foreign DNA into the Vaccinia Virus Genome by in Vitro Ligation: Recombination-Independent Selectable Cloning Vectors","volume":"189","author":"Merchlinsky","year":"1992","journal-title":"Virology"},{"key":"10.1016\/S0959-437X(05)80346-6_bib14_1","first-page":"9977","article-title":"Construction of Chimeric Vaccinia Viruses by Molecular Cloning and Packaging","volume":"89","author":"Scheiflinger","year":"1992"},{"key":"10.1016\/S0959-437X(05)80346-6_bib15","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1093\/nar\/18.14.4285","article-title":"New Vaccinia Virus Recombination Plasmids Incorporating a Synthetic Late Promoter for High Level Expression of Foreign Proteins","volume":"18","author":"Davison","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0959-437X(05)80346-6_bib16","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1128\/jvi.65.10.5584-5588.1991","article-title":"Increased Expression in Vivo and in Vitro of Foreign Genes Directed by A-Type Inclusion Body Hybrid Promoters in Recombinant Vaccinia Viruses","volume":"65","author":"Funahashi","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib17_1","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1128\/jvi.66.8.4710-4719.1992","article-title":"Mutational Analysis of the Core, Spacer and Initiator Regions of Vaccinia Virus Intermediate Class Promoters","volume":"66","author":"Baldick","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib18","article-title":"High Level Expression of Active Human Prothrombin in a Vaccinia Virus Expression System","volume":"68","author":"Falkner","year":"1992","journal-title":"Thromb Haemos"},{"key":"10.1016\/S0959-437X(05)80346-6_bib19","series-title":"Current Protocols in Molecular Biology","first-page":"16.19.1","article-title":"Gene Expression Using the Vaccinia Virus\/T7 RNA Polymerase Hybrid System","author":"Elroy-Stein","year":"1992"},{"key":"10.1016\/S0959-437X(05)80346-6_bib20","first-page":"520","article-title":"A New Cationic Liposome Reagent Mediating Nearly Quantitative Transfection of Animal Cells","volume":"10","author":"Rose","year":"1991","journal-title":"Biotechniques"},{"key":"10.1016\/S0959-437X(05)80346-6_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0092-8674(92)90619-N","article-title":"Infectious Defective Interfering Particles of VSV from Transcripts of a cDNA Clone","volume":"69","author":"Pattnaik","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0959-437X(05)80346-6_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0003-2697(91)90233-J","article-title":"Vaccinia-T7 RNA Polymerase Expression System: Evaluation for the Expression Cloning of Plasma Membrane Transporters","volume":"194","author":"Blakely","year":"1991","journal-title":"Anal Biochem"},{"key":"10.1016\/S0959-437X(05)80346-6_bib23","first-page":"10993","article-title":"Expression Cloning of a Reserpine-Sensitive Vesicular Monoamine Transporter","volume":"89","author":"Erickson","year":"1992"},{"key":"10.1016\/S0959-437X(05)80346-6_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-1119(91)90435-E","article-title":"Enhancement of the Vaccinia Virus\/Phage-T7 RNA Polymerase Expression System Using Encephalomyocarditis Virus 5\u2032-Untranslated Region Sequences","volume":"108","author":"Vennema","year":"1991","journal-title":"Gene"},{"key":"10.1016\/S0959-437X(05)80346-6_bib25_1","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/jvi.66.5.2934-2942.1992","article-title":"Regulated Expression of Foreign Genes in Vaccina Virus Under the Control of Bacteriophage T7 RNA Polymerase and the E. coli lac Repressor","volume":"66","author":"Alexander","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib26","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/jvi.64.10.4851-4857.1990","article-title":"Regulated Expression of Nuclear Genes by T3 RNA Polymerase and lac Repressor, Using Recombinant Vaccinia Virus Vectors","volume":"64","author":"Rodriguez","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib27","article-title":"SP6 RNA Polymerase Containing Vaccinia Virus for Rapid Expression of Cloned Genes in Tissue Culture","author":"Usdin","year":"1993","journal-title":"Biotechniques"},{"key":"10.1016\/S0959-437X(05)80346-6_bib28","series-title":"Recombinant Poxviruses","first-page":"235","article-title":"Safety and Attenuation of Vaccinia Virus","author":"Buller","year":"1992"},{"key":"10.1016\/S0959-437X(05)80346-6_bib29","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/jvi.66.5.2617-2630.1992","article-title":"Molecular Attenuation of Vaccinia Virus: Mutant Generation and Animal Characterization","volume":"66","author":"Lee","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib30","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/jvi.65.3.1530-1542.1991","article-title":"Identification and Characterization of Two Nonessential Regions of the Rabbitpox Virus Genome Involved in Virulence","volume":"65","author":"Bloom","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib31_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: A Highly Attenuated Strain of Vaccinia Virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"key":"10.1016\/S0959-437X(05)80346-6_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of Deletions in the Genome of the Highly Attenuated Vaccinia Virus MVA and their Influence on Virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib33_1","first-page":"10847","article-title":"Non-Replicating, Safety-Tested Vaccinia Vector Efficiently Expresses Recombinant Genes","volume":"89","author":"Sutter","year":"1992"},{"key":"10.1016\/S0959-437X(05)80346-6_bib34","series-title":"Recombinant Poxviruses","first-page":"123","article-title":"Poxvirus Recombinants as Live Vaccines","author":"Cox","year":"1992"},{"key":"10.1016\/S0959-437X(05)80346-6_bib35","first-page":"8011","article-title":"A Vaccinia Virus Double Recombinant Expressing the F and H Genes of Rinderpest Virus Protects Cattle Against Rinderpest and Causes no Pock Lesions","volume":"88","author":"Glavedoni","year":"1991"},{"key":"10.1016\/S0959-437X(05)80346-6_bib36","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/jvi.66.6.3950-3954.1992","article-title":"Protection of Macaques Against Infection with Simian Type-D Retrovirus (SRV-1) by Immunization with Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Either SRV-1 or Mason-Pfizer Monkey Virus (SRV-3)","volume":"66","author":"Brody","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib37_1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1531159","article-title":"Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160","volume":"255","author":"Hu","year":"1992","journal-title":"Science"},{"key":"10.1016\/S0959-437X(05)80346-6_bib38_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/354520a0","article-title":"Large-Scale Eradication of Rabies Using Recombinant Vaccinia-Rabies Vaccine","volume":"354","author":"Brochier","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0959-437X(05)80346-6_bib39_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0140-6736(91)91636-9","article-title":"Safety of and Immunological Response to a Recombinant Vaccinia Virus Vaccine Expressing HIV Envelope Glycoprotein","volume":"337","author":"Cooney","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S0959-437X(05)80346-6_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0042-6822(88)90692-7","article-title":"Successful Oral Rabies Vaccination of Raccoons with Raccoon Poxvirus Recombinants Expressing Rabies Virus Glycoprotein","volume":"167","author":"Esposito","year":"1988","journal-title":"Virology"},{"key":"10.1016\/S0959-437X(05)80346-6_bib41","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1128\/jvi.65.6.3400-3405.1991","article-title":"Raccoon Poxvirus Recombinants Expressing the Rabies Virus Nucleoprotein Protect Mice Against Lethal Rabies Virus Infection","volume":"65","author":"Lodmell","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib42","series-title":"Recombinant Poxviruses","first-page":"270","article-title":"Avipoxvirus vectors","author":"Boursnell","year":"1992"},{"key":"10.1016\/S0959-437X(05)80346-6_bib43_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0264-410X(91)90152-V","article-title":"Efficacy Studies on a Canarypox-Rabies Recombinant Virus","volume":"9","author":"Taylor","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/S0959-437X(05)80346-6_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01311302","article-title":"Construction of a Pigeonpox Virus Recombinant \u2014 Expression of the Newcastle Disease Virus (NDV) Fusion Glycoprotein and Protection of Chickens Against NDV Challenge","volume":"118","author":"Letellier","year":"1991","journal-title":"Arch Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib45","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1128\/jvi.66.3.1409-1413.1992","article-title":"Protection Against Marek's Disease by a Fowlpox Virus Recombinant Expressing the Glycprotein B of Marek's Diseases Virus","volume":"66","author":"Nazerian","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/S0959-437X(05)80346-6_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0264-410X(92)90411-C","article-title":"Potential Use of Non-Replicating Vectors as Recombinant Vaccines","volume":"10","author":"Baxby","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/S0959-437X(05)80346-6_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(88)90100-4","article-title":"Recombinant Fowlpox Virus Inducing Protective Immunity in Non-Avian Species","volume":"6","author":"Taylor","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/S0959-437X(05)80346-6_bib48_1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0140-6736(92)92027-D","article-title":"Immunisation with Canary-pox Virus Expressing Rabies Glycoprotein","volume":"339","author":"Cadoz","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0959-437X(05)80346-6_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0264-410X(90)90243-F","article-title":"Fowlpox Virus Recombinant Encoding the Measles Virus Fusion Protein \u2014 Protection of Mice Against Fatal Measles Encephalitis","volume":"8","author":"Wild","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/S0959-437X(05)80346-6_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0042-6822(92)90321-F","article-title":"Nonreplicating Viral Vectors as Potential Vaccines: Recombinant Canarypox Virus Expressing Measles Virus Fusion (F) and Hemagglutinin (HA) Glycoproteins","volume":"187","author":"Taylor","year":"1992","journal-title":"Virology"},{"key":"10.1016\/S0959-437X(05)80346-6_bib51","series-title":"Recombinant Poxviruses","first-page":"285","article-title":"Parapoxviruses: Their Biology and Potential as Recombinant Vaccines","author":"Robinson","year":"1992"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X05803466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X05803466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:33:22Z","timestamp":1760700802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X05803466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["S0959437X05803466"],"URL":"https:\/\/doi.org\/10.1016\/s0959-437x(05)80346-6","relation":{},"ISSN":["0959-437X"],"issn-type":[{"type":"print","value":"0959-437X"}],"subject":[],"published":{"date-parts":[[1993,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poxvirus vectors: cytoplasmic expression of transferred genes","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0959-437X(05)80346-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1993 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}